{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:18:18Z","timestamp":1695871098523},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T00:00:00Z","timestamp":1445990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10620-015-3864-9","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T07:36:56Z","timestamp":1446017816000},"page":"230-237","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of Thiopurine Treatment Failure in Biologic-Na\u00efve Ulcerative Colitis Patients"],"prefix":"10.1007","volume":"61","author":[{"given":"Sudeep Dhoj","family":"Thapa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Hadid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Imam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Schairer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed-Mohammed R.","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"key":"3864_CR1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713\u20131725. doi: 10.1056\/NEJMra1102942 .","journal-title":"N Engl J Med"},{"key":"3864_CR2","author":"E Louis","year":"2014","unstructured":"Louis E, Irving P, Beaugerie L. Use of azathioprine in IBD: modern aspects of an old drug. Gut. 2014;. doi: 10.1136\/gutjnl-2013-306711 .","journal-title":"Gut"},{"key":"3864_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","volume":"50","author":"AG Fraser","year":"2002","unstructured":"Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30\u00a0year review. Gut. 2002;50:485\u2013489.","journal-title":"Gut"},{"key":"3864_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","volume":"305","author":"AB Hawthorne","year":"1992","unstructured":"Hawthorne AB, Logan RF, Hawkey CJ, et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ. 1992;305:20\u201322.","journal-title":"BMJ"},{"key":"3864_CR5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.crohns.2014.03.014","volume":"8","author":"A Ca\u00f1as-Ventura","year":"2014","unstructured":"Ca\u00f1as-Ventura A, M\u00e1rquez L, Ricart E, et al. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment. J Crohns Colitis. 2014;8:1287\u20131293. doi: 10.1016\/j.crohns.2014.03.014 .","journal-title":"J Crohns Colitis"},{"key":"3864_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2036.2009.04023.x","volume":"30","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Linares PM, McNicholl AG, Mat\u00e9 J, Gomoll\u00f3n F. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther. 2009;30:126\u2013137. doi: 10.1111\/j.1365-2036.2009.04023.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"3864_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/17474124.2.1.23","volume":"2","author":"I Atreya","year":"2008","unstructured":"Atreya I, Neurath MF. Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications. Expert Rev Gastroenterol Hepatol. 2008;2:23\u201334. doi: 10.1586\/17474124.2.1.23 .","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3864_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/egh.10.59","volume":"4","author":"C Ha","year":"2010","unstructured":"Ha C, Dassopoulos T. Thiopurine therapy in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4:575\u2013588. doi: 10.1586\/egh.10.59 .","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3864_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ajg.2013.462","volume":"109","author":"S Chatu","year":"2014","unstructured":"Chatu S, Saxena S, Subramanian V, et al. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn\u2019s disease: national UK population-based study 1989\u20132010. Am J Gastroenterol. 2014;109:409\u2013416. doi: 10.1038\/ajg.2013.462 .","journal-title":"Am J Gastroenterol"},{"key":"3864_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000007823","volume":"62","author":"ZH Khan","year":"2000","unstructured":"Khan ZH, Mayberry JF, Spiers N, Wicks AC. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience. Digestion. 2000;62:249\u2013254. doi: 10.1159\/000007823 .","journal-title":"Digestion"},{"key":"3864_CR11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.dld.2008.03.016","volume":"40","author":"S Saibeni","year":"2008","unstructured":"Saibeni S, Virgilio T, D\u2019Inc\u00e0 R, et al. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice. Dig Liver Dis. 2008;40:814\u2013820. doi: 10.1016\/j.dld.2008.03.016 .","journal-title":"Dig Liver Dis"},{"key":"3864_CR12","unstructured":"National Health Accounts Historical 2014. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/NationalHealthExpendData\/NationalHealthAccountsHistorical.html . Accessed December 16, 2014."},{"key":"3864_CR13","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1007\/s10620-012-2289-y","volume":"57","author":"C Gunnarsson","year":"2012","unstructured":"Gunnarsson C, Chen J, Rizzo JA, Ladapo JA, Lofland JH. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey. Dig Dis Sci. 2012;57:3080\u20133091. doi: 10.1007\/s10620-012-2289-y .","journal-title":"Dig Dis Sci"},{"key":"3864_CR14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrgastro.2009.222","volume":"7","author":"GR D\u2019Haens","year":"2010","unstructured":"D\u2019Haens GR. Top-down therapy for IBD: rationale and requisite evidence. Nat Rev Gastroenterol Hepatol. 2010;7:86\u201392. doi: 10.1038\/nrgastro.2009.222 .","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3864_CR15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/ibd.21488","volume":"17","author":"KT Park","year":"2011","unstructured":"Park KT, Bass D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflamm Bowel Dis. 2011;17:1603\u20131609. doi: 10.1002\/ibd.21488 .","journal-title":"Inflamm Bowel Dis"},{"key":"3864_CR16","unstructured":"Hanson K, Benouna SME. Managing the costs of your IBD care 2013. http:\/\/www.ccfa.org\/assets\/pdfs\/managing-costs-of-ibd.pdf . Accessed December 17, 2014."},{"key":"3864_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10930-012-9449-y","volume":"31","author":"J Sochacka","year":"2012","unstructured":"Sochacka J, Baran W. The investigation of the binding of 6-mercaptopurine to site I on human serum albumin. Protein J. 2012;31:689\u2013702. doi: 10.1007\/s10930-012-9449-y .","journal-title":"Protein J"},{"key":"3864_CR18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03190876","volume":"33","author":"C Tesseromatis","year":"2008","unstructured":"Tesseromatis C, Alevizou A. The role of the protein-binding on the mode of drug action as well the interactions with other drugs. Eur J Drug Metab Pharmacokinet. 2008;33:225\u2013230.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"3864_CR19","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/MIB.0000000000000212","volume":"20","author":"I Dotan","year":"2014","unstructured":"Dotan I, Ron Y, Yanai H, et al. Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study. Inflamm Bowel Dis. 2014;20:2247\u20132259. doi: 10.1097\/MIB.0000000000000212 .","journal-title":"Inflamm Bowel Dis"},{"key":"3864_CR20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00228-009-0718-4","volume":"65","author":"AA Fasanmade","year":"2009","unstructured":"Fasanmade AA, Adedokun OJ, Ford J, et al. Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis. Eur J Clin Pharmacol. 2009;65:1211\u20131228. doi: 10.1007\/s00228-009-0718-4 .","journal-title":"Eur J Clin Pharmacol"},{"key":"3864_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5414\/CPP48297","volume":"48","author":"AA Fasanmade","year":"2010","unstructured":"Fasanmade AA, Adedokun OJ, Olson A, Strauss R, Davis HM. Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis. Int J Clin Pharmacol Ther. 2010;48:297\u2013308.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"3864_CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.2.4884.375","volume":"2","author":"SC Truelove","year":"1954","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954;2:375\u2013378.","journal-title":"Br Med J"},{"key":"3864_CR23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MPG.0b013e3182619d26","volume":"55","author":"LI Kelley-Quon","year":"2012","unstructured":"Kelley-Quon LI, Jen HC, Ziring DA, et al. Predictors of proctocolectomy in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2012;55:534\u2013540. doi: 10.1097\/MPG.0b013e3182619d26 .","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3864_CR24","author":"D Stabroth-Akil","year":"2014","unstructured":"Stabroth-Akil D, Leifeld L, Pf\u00fctzer R, Morgenstern J, Kruis W. The effect of body weight on the severity and clinical course of ulcerative colitis. Int J Colorectal Dis. 2014. doi: 10.1007\/s00384-014-2051-3 .","journal-title":"Int J Colorectal Dis"},{"key":"3864_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/clnu.2001.0503","volume":"21","author":"A Blain","year":"2002","unstructured":"Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Crohn\u2019s disease clinical course and severity in obese patients. Clin Nutr. 2002;21:51\u201357. doi: 10.1054\/clnu.2001.0503 .","journal-title":"Clin Nutr"},{"key":"3864_CR26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cgh.2005.12.015","volume":"4","author":"DJ Hass","year":"2006","unstructured":"Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR. The impact of increased body mass index on the clinical course of Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2006;4:482\u2013488. doi: 10.1016\/j.cgh.2005.12.015 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3864_CR27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"RB Sartor","year":"2006","unstructured":"Sartor RB. Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390\u2013407. doi: 10.1038\/ncpgasthep0528 .","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"3864_CR28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gutjnl-2011-301424","volume":"62","author":"LI Kredel","year":"2013","unstructured":"Kredel LI, Batra A, Stroh T, et al. Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn\u2019s disease. Gut. 2013;62:852\u2013862. doi: 10.1136\/gutjnl-2011-301424 .","journal-title":"Gut"},{"key":"3864_CR29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gut.2004.046516","volume":"54","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K, Kiyohara T, Murayama Y, et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn\u2019s disease. Gut. 2005;54:789\u2013796. doi: 10.1136\/gut.2004.046516 .","journal-title":"Gut"},{"key":"3864_CR30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/MIB.0000000000000188","volume":"20","author":"H Iskandar","year":"2014","unstructured":"Iskandar H, Greer JB, Schraut WH, et al. IBD LIVE case series-case 1: smoking, a controversial but effective treatment for ulcerative colitis. Inflamm Bowel Dis. 2014;20:1696\u20131701. doi: 10.1097\/MIB.0000000000000188 .","journal-title":"Inflamm Bowel Dis"},{"key":"3864_CR31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1572-0241.2007.01065.x","volume":"102","author":"MC Aldhous","year":"2007","unstructured":"Aldhous MC, Drummond HE, Anderson N, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007;102:589\u2013597. doi: 10.1111\/j.1572-0241.2007.01065.x .","journal-title":"Am J Gastroenterol"},{"key":"3864_CR32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0016-5085(87)91021-3","volume":"93","author":"MV Tobin","year":"1987","unstructured":"Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT. Cigarette smoking and inflammatory bowel disease. Gastroenterology. 1987;93:316\u2013321.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3864-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3864-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3864-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:49:55Z","timestamp":1559231395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3864-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3864"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3864-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,28]]}}}